Timasheva, Y.,
Balkhiyarova, Z.,
Avzaletdinova, D.,
Rassoleeva, I.,
Morugova, T.V.,
Korytina, G.,
Prokopenko, I.,
Kochetova, O. (2023) (OR = 1.99, PFDR = 0.033), ADIPOQ rs17366743 (OR = 3.17, PFDR =
2.64 × 10−4),
TCF7L2 rs114758349 (OR
1C, GABBR
2,
TCF7L2, DCK, NRP1, PBX1, FANCC, CCDC88C,
TCF12, and ABLIM1 genes. Prevention
ЛОНГИТЮДНЫЕ ГЕНЕТИЧЕСКИЕ ИССЛЕДОВАНИЯ КОГНИТИВНЫХ ХАРАКТЕРИСТИКМУСТАФИН, Р.Н.,
КАЗАНЦЕВА, А.В.,
ЕНИКЕЕВА, Р.Ф.,
МАЛЫХ, С.Б.,
ХУСНУТДИНОВА, Э.К.,
Mustafin R.N.,
Kazantseva A.V.,
Enikeeva R.F.,
Malykh S.B.,
Khusnutdinova E.K. (2020) хроматина (ACTB, ARID1A, ARID1B, ATRX, CHD
2, CHD
7, CHD8, SMARCA
2, SMARCA4, SMARCB1, SMARCE1, SRCAP, SS18
L1
The reaction of 8-bromo-substituted 3-methyl-
7-(thietan-3-yl)-3,
7-dihydro-1H-purine-
2,6-diones
Smirnova, L. A.,
Spasov, A. A.,
Khaliullin, F. A.,
Kucheryavenko, A. F.,
Ryabukha, A. F.,
Abramov, O. K. (2021) antiplatelet drug 3-methyl-8-(piperazin-1-yl)-
7-(thietan-3-yl)-1-ethyl-1H-purine-
2,6(3H,
7H)-dione hydrochloride